STOCK TITAN

YIELD10 BISCIENCE INC NEW - YTEN STOCK NEWS

Welcome to our dedicated page for YIELD10 BISCIENCE NEW news (Ticker: YTEN), a resource for investors and traders seeking the latest updates and insights on YIELD10 BISCIENCE NEW stock.

Yield10 Bioscience, Inc. (Nasdaq: YTEN) is a pioneering agricultural bioscience company focusing on the development of cutting-edge technologies for significant improvements in crop yield within the United States and Canada. Founded in 1992 and headquartered in Woburn, Massachusetts, Yield10 leverages advanced genetic engineering to develop high-value traits in seeds, targeting the agriculture and food industries through its Trait Factory. The company has a dedicated oilseed development center in Saskatchewan, Canada.

The core mission of Yield10 is to harness the genetic potential of the oilseed Camelina sativa ('Camelina') for the production of sustainable seed products. These products include feedstock oils for renewable diesel and sustainable aviation biofuels, omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical, and aquafeed applications, and future plans for PHA biomaterials to be used as biodegradable bioplastics.

Yield10’s research initiatives are bolstered by strategic partnerships with industry giants such as Bayer AG for soybean traits, Forage Genetics International, LLC for forage sorghum traits, J. R. Simplot Company for potato traits, and GDM Seeds Inc. for evaluating yield traits in soybeans. These collaborations underscore the company’s commitment to innovation and broadening the impact of its technologies.

Significant recent milestones include the development and successful field testing of proprietary winter Camelina varieties engineered for herbicide tolerance. These varieties showed promising results in tolerating glufosinate and Group 2 herbicides, which are crucial for managing weeds and ensuring high yield in crop rotations across North America. This advancement is expected to facilitate the large-scale adoption of Camelina for biofuel and omega-3 oil markets, with the potential for commercial production as early as 2025.

Regulatory progress has been a key aspect of Yield10’s strategy, with USDA-APHIS determining that its genetically engineered Camelina traits are not subject to certain regulations, allowing for expanded planting and breeding in the United States. Additionally, the Canadian Food Inspection Agency has cleared Yield10's E3902 Camelina, which features enhanced oil production and a lighter seed coat.

Yield10 continues to build on its commercial and regulatory achievements, exemplified by the recent agreement with Vision Bioenergy Oilseeds to license Camelina varieties for biofuel feedstock production. This collaboration aims to support the growing demand for low-carbon intensity feedstock oil, aligning with global decarbonization goals.

For more detailed information about Yield10 Bioscience and its innovative endeavors, visit www.yield10bio.com or follow the company on X (formerly Twitter), Facebook, and LinkedIn.

Rhea-AI Summary
Yield10 Bioscience and BioMar Group have signed an LOI to form a long-term partnership to commercialize a Camelina crop containing enriched levels of EPA and DHA equal to fish oil. This Omega-3 Camelina technology has the potential to become an important supplement to the scarce supply of marine long-chain fatty acids. Yield10 expects to scale-up planted acres of Camelina to supply BioMar with oil for formulation and testing while also working towards securing regulatory approval for commercial production of Omega-3 Camelina oil and meal.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.45%
Tags
none
-
Rhea-AI Summary
Sono-Tek Corporation to present at the Fall Foliage MicroCap Rodeo Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.11%
Tags
conferences
-
Rhea-AI Summary
Yield10 Bioscience exercises option to finalize exclusive global license for omega-3 production technology from Rothamsted Research
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.13%
Tags
none
Rhea-AI Summary
Yield10 Bioscience announces advancements in herbicide tolerant Camelina for biofuel market
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.15%
Tags
none
-
Rhea-AI Summary
Yield10 Bioscience begins revenue generation for its 'Camelina Seed Genetics to Biofuel' platform as the harvest of Camelina grain is completed and delivered to an offtake partner for biofuel production. Revenue from Camelina grain sales expected to be a key contributor to the company's financial profile. Focus now on building technology foundation to accelerate grower adoption of Camelina for the biofuels market. Positive feedback from growers and plans to secure grower contracts for harvest in Q3 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.03%
Tags
none
-
Rhea-AI Summary
Yield10 Bioscience to participate in H.C. Wainwright 25th Annual Global Investment Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.56%
Tags
conferences
Rhea-AI Summary
Yield10 Bioscience, Inc. has closed its public offering of 5,750,000 units at a price of $0.65 per unit, resulting in gross proceeds of approximately $3.7 million. Each unit consists of one share of common stock and one warrant to purchase one share of common stock. The warrants are exercisable at $0.65 per share and expire in five years. Maxim Group LLC and Lake Street Capital Markets, LLC acted as joint placement agents for the offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-55.45%
Tags
Rhea-AI Summary
Yield10 Bioscience, Inc. announces the pricing of its public offering of 5,750,000 units at a price of $0.65 per unit, with expected gross proceeds of approximately $3.7 million. The offering is expected to close on August 15, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-55.45%
Tags

FAQ

What is the current stock price of YIELD10 BISCIENCE NEW (YTEN)?

The current stock price of YIELD10 BISCIENCE NEW (YTEN) is $0.3501 as of December 9, 2024.

What is the market cap of YIELD10 BISCIENCE NEW (YTEN)?

The market cap of YIELD10 BISCIENCE NEW (YTEN) is approximately 1.5M.

What does Yield10 Bioscience do?

Yield10 Bioscience develops advanced genetic engineering technologies to improve crop yield, focusing on the oilseed Camelina for biofuel and omega-3 oil production.

Where is Yield10 Bioscience headquartered?

Yield10 Bioscience is headquartered in Woburn, Massachusetts, USA.

What are some recent achievements of Yield10 Bioscience?

Recent achievements include successful herbicide tolerance tests for winter Camelina and regulatory approvals from USDA-APHIS and CFIA for their genetically engineered Camelina traits.

Who are Yield10 Bioscience’s key partners?

Key partners include Bayer AG, Forage Genetics International, J. R. Simplot Company, and GDM Seeds Inc.

What is Camelina sativa?

Camelina sativa is an oilseed crop developed by Yield10 for producing sustainable feedstock oils for biofuels, omega-3 oils for nutrition, and potentially biodegradable bioplastics.

What is the significance of Yield10’s herbicide tolerance tests?

Herbicide tolerance tests for Camelina showed promising results, indicating that the crop can withstand common herbicides, facilitating large-scale agricultural adoption and enhancing yield.

What are Yield10’s future plans for Camelina?

Future plans include commercializing omega-3 oil products, developing biodegradable bioplastics, and establishing grain contracts for biofuel feedstock production.

What regulatory milestones has Yield10 achieved?

Yield10 has received USDA-APHIS clearance for planting genetically engineered Camelina and CFIA approval for its E3902 variety, paving the way for expanded commercial cultivation.

How is Yield10 addressing the demand for omega-3 oils?

Yield10 is developing Camelina varieties engineered to produce omega-3 fatty acids, providing a sustainable alternative to fish oil and meeting the growing demand in aquafeed and nutritional markets.

Where can I find more information about Yield10 Bioscience?

More information can be found on their website at www.yield10bio.com or by following them on X (formerly Twitter), Facebook, and LinkedIn.

YIELD10 BISCIENCE INC NEW

Nasdaq:YTEN

YTEN Rankings

YTEN Stock Data

1.52M
567.28k
17.55%
0.03%
0.39%
Agricultural Inputs
Basic Materials
Link
United States of America
WOBURN